Skip to content

Registry of Multicenter Brain-Heart Comorbidity in China

Registry of Multicenter Brain-Heart Comorbidity in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05961748
Acronym
BHC-C
Enrollment
100000
Registered
2023-07-27
Start date
2012-01-01
Completion date
2032-12-31
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Diseases, Arteriovenous Malformation of Cerebral Vessels, Atrial Fibrillation, Cardiac Arrest, Cerebral Aneurysm, Cerebral Infarction, Heart Failure, Intracerebral Hemorrhage, Ischemic Heart Disease, Moyamoya Disease, Occlusion and Stenosis of Cerebellar Arteries, Occlusion and Stenosis of Precerebral Arteries, Subarachnoid Hemorrhage

Brief summary

This study is a multi-center, prospective, registry study. This research was supported by the National Key Research and Development Program. To establish a domestic multi-center, large-scale brain-heart comorbidity dynamic database platform including clinical, sample database, image and other multi-dimensional information requirements, through the construction of a multi-center intelligent scientific research integration platform based on artificial intelligence. Any of newly diagnosed cardiovascular related diseases were identified via ICD-10-CM codes: I21, I22, I24 (Ischaemic heart diseases) \[i.e., ACS\], I46 (cardiac arrest), I48 (Atrial fibrillation/flutter), I50 (Heart failure), I71 (Aortic disease), I60 (subarachnoid hemorrhage), I61 (intracerebral hemorrhage), I63 (Cerebral infarction), I65 (Occlusion and stenosis of precerebral arteries), I66 (Occlusion and stenosis of cerebral arteries), I67.1 (cerebral aneurysm), I67.5 (moyamoya diseases), Q28.2 (Arteriovenous malformation of cerebral vessels). The data is stored on the brain-heart comorbidity warehouse via a physical server at the institution's data centre or a virtual hosted appliance. The brain-heart comorbidity platform comprises of a series of these appliances connected into a multicenter network. This network can broadcast queries to each appliance. Results are subsequently collected and aggregated. Once the data is sent to the network, it is mapped to a standard and controlled set of clinical terminologies and undergoes a data quality assessment including 'data cleaning' that rejects records which do not meet the brain-heart comorbidity quality standards. The brain-heart comorbidity warehouse performs internal and extensive data quality assessment with every refresh based on conformance, completeness, and plausibility (http://10.100.101.65:30080/login).

Interventions

Multi-disciplinary assessment

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* age \> 18 years old * Any of newly diagnosed cardiovascular-related diseases were identified via ICD-10-CM codes: I21, I22, I24 (Ischaemic heart diseases) \[i.e., ACS\], I46 (cardiac arrest), I48 (Atrial fibrillation/flutter), I50 (Heart failure), I71 (Aortic disease), I60 (subarachnoid hemorrhage), I61 (intracerebral hemorrhage), I63 (Cerebral infarction), I65 (Occlusion and stenosis of precerebral arteries), I66 (Occlusion and stenosis of cerebral arteries), I67.1 (cerebral aneurysm), I67.5 (moyamoya diseases), Q28.2 (Arteriovenous malformation of cerebral vessels).

Exclusion criteria

·refuse to participate in the registry

Design outcomes

Primary

MeasureTime frameDescription
Rate of Participants with Composite of All-Cause Mortality and Cardiovascular OutcomesAt discharge/30 daysThe occurrence of all-cause mortality, coronary artery disease event, stroke (ischemic or hemorrhagic), heart failure, or atrial fibrillation etc.
All-Cause MortalityAt discharge/30 daysThe occurrence of death
Rate of Participants with Composite of Cardiovascular OutcomesAt discharge/30 daysThe occurrence of coronary artery disease event, stroke (ischemic or hemorrhagic), heart failure, or atrial fibrillation etc.

Countries

China

Contacts

Primary ContactXiaolin Chen, MD
cxl_bjtth@163.com13810624845
Backup ContactFa Lin, MD
13681107240@163.com13681107240

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026